Company / Operating Cash Flow per Share
PLUS THERAPEUTICS, INC. Operating Cash Flow per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.79
FY2025
5-year range
-$3.13 / -$0.10
FY2021-FY2025
Trend
+38.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-3.13 in FY2018 to $-0.10 in FY2017.
Based on SEC 10-K filings.
-1.79 in FY2025.
Improved from $-3.13 to $-1.79 over the past 7 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 38.1% year-over-year.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.79 | +38.1% |
| FY2024 | -$2.89 | +7.8% |
| FY2018 | -$3.13 | -3109.9% |
| FY2017 | -$0.10 | +93.8% |
| FY2016 | -$1.57 | -352.4% |
| FY2015 | -$0.35 | +22.9% |
| FY2014 | -$0.45 | +15.8% |
| FY2013 | -$0.54 | -28.7% |
| FY2012 | -$0.42 | +9.1% |
| FY2011 | -$0.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026